Olema Pharmaceuticals Inc... (OLMA)
undefined
undefined%
At close: undefined
6.77
0.97%
After-hours Dec 13, 2024, 05:55 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue - - - - - -
Cost of Revenue 377.00K 1.66M 1.66M 11.00K 9.03K 8.24K
Gross Profit -377.00K -1.66M -1.66M -11.00K -9.03K -8.24K
Operating Income -104.96M -106.99M -71.49M -21.53M -4.32M -2.08M
Interest Income 8.32M 2.23M 442.00K 60.00K 7.00K 4.00K
Pretax Income -96.66M -104.79M -71.10M -22.12M -4.32M -2.20M
Net Income -96.66M -102.59M -70.89M -22.76M -4.32M -2.20M
Selling & General & Admin 18.82M 24.71M 20.39M 7.82M 403.00K 386.00K
Research & Development 86.14M 82.27M 51.10M 13.70M 3.92M 1.69M
Other Expenses - -27.00K -47.00K - - -31.00K
Operating Expenses 104.96M 106.99M 71.49M 21.53M 4.32M 2.08M
Interest Expense - - - 653.00K - 28.00K
Selling & Marketing Expenses - - - - - -
Cost & Expenses 104.96M 106.99M 71.49M 21.53M 4.32M 2.08M
Income Tax - -2.20M -210.00K 642.00K -155.86K -90.00K
Shares Outstanding (Basic) 45.25M 40.00M 39.52M 39.31M 40.17M 14.10M
Shares Outstanding (Diluted) 45.25M 40.00M 39.52M 39.31M 40.17M 14.10M
EPS (Basic) -2.14 -2.56 -1.79 -0.58 -0.11 -0.16
EPS (Diluted) -2.14 -2.56 -1.79 -0.58 -0.11 -0.16
EBITDA -104.58M -103.13M -69.43M -21.52M -4.31M -2.16M
Depreciation & Amortization 377.00K 1.66M 1.66M 11.00K 9.03K 8.24K